Domov › Shizofrenija › Texas

Klinične študije za Shizofrenija v Texas

34 študij za Shizofrenija išče udeležence na lokacijah v Texas.

Mesta v Texas

Uradno besedilo študije (angleško)

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Haracec Clinical Research, El Paso
C-Trilogy Outreach, Longview

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07101094

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Community Clinical Research, Inc., Austin
Pillar Clinical Research, LLC, Richardson

Vključevanje udeležencevFaza 1

Starost 18–55 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Local Institution - 0049, Austin
Local Institution - 0194, Dallas
Pillar Clinical Research - Richardson, Richardson

Vključevanje udeležencevFaza 3

Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Texas Research Group, Coppell
PsyMed Solutions, Fort Worth
Kaleidoscope Clinical Research, Houston
in še 3

Vključevanje udeležencevFaza 3

Starost 5–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06229210

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Neurocrine Clinical Site, Austin
Neurocrine Clinical Site, DeSoto
Neurocrine Clinical Site, Houston

Vključevanje udeležencevFaza 3

Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Neurocrine Clinical Site, DeSoto

Vključevanje udeležencevFaza 3

Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07227818

Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia

TG Therapeutics Investigational Trial Site, Richardson

Vključevanje udeležencevFaza 2

Starost 18–60 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07680946

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Local Institution - 0149, Dallas
VAST Clinical Research, Garland
Local Institution - 0169, Houston
in še 2

Vključevanje udeležencevFaza 3

Starost 5–17 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

Adams Clinical Dallas, DeSoto
Re:Cognition Health - Fort Worth, Fort Worth

Vključevanje udeležencevFaza 2

Starost 18–55 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07410507

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Neurocrine Clinical Site, Austin

Vključevanje udeležencevFaza 4

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07105111

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

Pillar Clinical Research, LLC, Richardson

Vključevanje udeležencevFaza 1

Starost 18–55 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07734493

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

The University of Texas Health Science Center, Houston, Houston

Vključevanje udeležencev

Starost 22–65 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT05276050

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

Community Clinical Research - Cross Park Drive /ID# 272977, Austin
Pillar Clinical Research - Richardson /ID# 275715, Richardson

Vključevanje udeležencevFaza 2

Starost 18–65 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07145918

52-week Open Label Safety-Tolerability Study

Adams Clinical, DeSoto
Pillar Clinical Research, Richardson

Vključevanje udeležencevFaza 3

Starost 18–65 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

VAST Clinical Research, Garland
Local Institution - 0120, Houston
Local Institution - 0066, Spring

Vključevanje udeležencevFaza 3

Starost 13–17 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Community Clinical Research, Austin

Vključevanje udeležencevFaza 1

Starost 18–55 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Clinical Site, Austin
Clinical Site, DeSoto
Clinical Site, Richardson

Vključevanje udeležencevFaza 2

Starost 18–65 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Local Institution - 0016, Austin
Local Institution - 0050, Dallas
Local Institution - 0021, Fort Worth
in še 10

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07379827

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

BioXcel Clinical Research Site, DeSoto

Vključevanje udeležencevFaza 1

Starost 10–17 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05025605

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

The University of Texas Health Science Center at Houston, Houston

Vključevanje udeležencev

Starost 18–60 · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07060066

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

The University of Texas Health Science Center at Houston, Houston

Vključevanje udeležencev

Starost 18–50 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT02916810

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)

The University of Texas Health Science Center, Houston, Houston

Vključevanje udeležencev

Starost 18–60 · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06961916

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

The University of Texas Health Science Center, Houston, Houston

Vključevanje udeležencev

Starost 18–60 · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06345963

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Community Clinical Research, Austin

Vključevanje udeležencevFaza 2

Starost 18–55 · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07191483

Deep Brain Stimulation for Psychosis

UT Southwestern Medical Center, Dallas

Vključevanje udeležencev

Starost 22–70 · Vsi spoli · Posodobljeno 9. jun. 2026 · NCT06257056

A Study to Evaluate the Effect of KarXT on Urological Safety

Local Institution - 0001, Austin
InSite Clinical Research, DeSoto

Vključevanje udeležencevFaza 4

Starost 18–65 · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT07221877

CLOZAPINE Response in Biotype-1

UT Southwestern Medical Center, Dallas

Vključevanje udeležencevFaza 4

Starost 18–60 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT04580134

Database Registry for Neural Network Biomarkers in Psychosis

University of Texas Southwestern Medical Center, Dallas

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 18–60 · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT01409109

Ocrelizumab for Psychosis by Autoimmunity

Houston Methodist Research Institute, Houston

Vključevanje udeležencevFaza 1/2

Starost 18–35 · Vsi spoli · Posodobljeno 1. apr. 2026 · NCT03971487

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

University of Texas Southwestern Medical Center, Dallas

Vključevanje udeležencevOpazovalna študija

Starost 18–40 · Vsi spoli · Posodobljeno 10. mar. 2026 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Neurocrine Clinical Site, Austin
Neurocrine Clinical Site, DeSoto
Neurocrine Clinical Site, Houston

Vključevanje udeležencevFaza 3

Starost 18–65 · Vsi spoli · Posodobljeno 6. mar. 2026 · NCT06963034

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

University of Texas at Dallas, Dallas

Vključevanje udeležencev

Starost 18–65 · Vsi spoli · Posodobljeno 23. jan. 2026 · NCT07098169

Randomized Withdrawal Study in Patients With Schizophrenia

Vanda Investigational Site, Austin
Vanda Investigational Site, Houston
Vanda Investigational Site, Irving
in še 1

Vključevanje udeležencevFaza 3

Starost 18–65 · Vsi spoli · Posodobljeno 12. jan. 2026 · NCT06961968

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Reviva site, Austin
Reviva site, Richardson

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci

Starost 18–65 · Vsi spoli · Posodobljeno 19. dec. 2024 · NCT05184335

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.